研究单位：[1]Section Head,Sichuan Cancer Hospital and Research Institute[2]General Hospital of Ningxia Medical University[3]First Affiliated Hospital Xi'an Jiaotong University[4]Affiliated Hospital of Southwest Medical University[5]Chongqing Three Gorges Central Hospital
研究目的：
This study evaluated the effectiveness and safety of sintilimab combined with cCRT in patients with locally advanced ESCC.
